Numbers

Qwen View

The Numbers

HCL Technologies trades at a 22.6x P/E — a modest premium to TCS (17.8x) and Infosys (18.4x), but well below high-growth peers like Persistent (46.7x). The stock's rerating hinges on one metric: operating margin expansion. At 21.7% in FY2025, HCL sits below TCS/INFY's 24-26% range. A 100-bps margin improvement would add ~₹17B to annual profits, justifying a higher multiple.

Revenue & Profit Trajectory

Revenue has grown 66% over 5 years (CAGR ~11%), accelerating post-FY2022 as large deal wins converted to revenue. Net income growth (57% over 5 years) lagged slightly due to margin pressure from wage inflation and utilization headwinds.

Q3 FY26 revenue of ₹338.7B marks the highest quarterly revenue ever for HCL, up 13% YoY. However, net income dipped to ₹40.8B from ₹45.9B in Q3 FY25 — margin compression remains the key concern despite top-line strength.

Operating Margin — The Critical Metric

HCL's margin has compressed 470 bps from the FY2021 peak (26.6%) to FY2025 (21.8%), while TCS/INFY held 24-27%. This 400-500 bps gap vs peers is the primary reason HCL trades at a discount to its quality. The market needs to see margin stabilization before rerating.

Cash Generation — Exceptional Quality

HCL converts 95% of operating cash flow to free cash flow — among the best in Indian IT. Low capex intensity (SaaS/consulting model) means nearly all cash generated is available for shareholders. FCF of ₹212B in FY2025 implies a 5.5% FCF yield at current market cap.

FCF margins have held 175-195% of net income — a rare metric indicating earnings are highly cash-backed. The 94% payout ratio in FY2025 leaves minimal room for buybacks, but dividend growth remains sustainable.

Balance Sheet — Fortress Strength

Debt/Equity stands at 0.09x — essentially net cash. HCL carries ₹63B debt against ₹697B equity, with ₹76B in investments on the balance sheet. This provides ample flexibility for M&A or buybacks if management chooses to deploy capital more aggressively.

ROCE has improved 700 bps from the FY2022 trough (25%) to FY2025 (32%), reflecting better capital efficiency despite margin pressure. This is a positive signal that management is optimizing asset utilization even as pricing remains challenged.

Peer Valuation Comparison

HCL sits in the middle of the pack — higher P/E than TCS/INFY/WIPRO but lower ROE than TCS/INFY. The valuation implies the market expects margin recovery. LTM and Persistent trade at significant premiums (27-47x) despite lower ROE, reflecting growth expectations in niche segments.

Shareholding Pattern

Promoter stake remains stable at 60.8% — a strong anchor. FII holding dropped from 19.4% (Q3 FY25) to 16.2% (Q3 FY26), while DII increased from 15.2% to 18.4%. This suggests domestic institutions are accumulating as foreign investors reduce exposure — a typical pattern during INR volatility or global risk-off periods.

What the Numbers Confirm

The balance sheet is fortress-strong (0.09x D/E), cash conversion is exceptional (95% OCF→FCF), and ROCE is improving (32% in FY2025). HCL is a high-quality business trading at a reasonable 22.6x P/E with a 3.7% dividend yield.

What the Numbers Contradict

Despite quality, margins have compressed 470 bps from peak (26.6% → 21.8%), and revenue growth has slowed to ~6-7% in recent quarters. The market is pricing in continued margin pressure — HCL trades at a 20-25% discount to TCS/INFY on P/E despite similar business models.

What to Watch Next Quarter

Q4 FY26 operating margin is the single most important metric. If HCL can demonstrate margin stabilization above 22% (vs 21.8% in FY2025), the stock could rerate toward 25x P/E. Conversely, further compression below 21% would justify the current discount. Also monitor FII/DII flows — sustained DII accumulation could provide a valuation floor.